date,title,source
Nov-01-18,Aptinyx Completes Enrollment in Phase 2 Study of NYX-2925 for Painful Diabetic Peripheral Neuropathy,GlobeNewswire
Nov-12-18,"Aptinyx Exploratory Clinical Studies Provide First Evidence that NYX-2925 Elicits Rapid, Persistent, NMDAr-Mediated Pharmacodynamic Activity in Humans",GlobeNewswire
Nov-13-18,Aptinyx Reports Third Quarter 2018 Financial Results and Business Highlights,GlobeNewswire
Nov-21-18,"Factors of Influence in 2018, Key Indicators and Opportunity within Atlantic American, Titan Medical, Adial Pharmaceuticals, Aptinyx, Sotherly Hotels, and Titan Pharmaceuticals  New Research Emphasizes Economic Growth",GlobeNewswire
Dec-03-18,Aptinyx Reports Positive Data from Interim Analysis of Exploratory Study of NYX-2925 in Subjects with Fibromyalgia,GlobeNewswire
Dec-11-18,Aptinyx to Present Preclinical Data on NMDA Receptor Modulator NYX-2925 at the American College of Neuropsychopharmacologys Annual Meeting,GlobeNewswire
Dec-20-18,Should You Take Comfort From Insider Transactions At Aptinyx Inc. (NASDAQ:APTX)?,Simply Wall St.
Jan-02-19,Aptinyx to Present at 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-16-19,Biotech Play Aptinyx Tanks After Drug Trial Fails,TheStreet.com
Jan-16-19,"Why Ford Motor, Snap, and Aptinyx Slumped Today",Motley Fool
Jan-16-19,Here's Why Aptinyx Got Crushed Today,Motley Fool
Jan-16-19,Aptinyx stock falls 67% after phase 2 trial fails to meet primary endpoint,MarketWatch
Jan-16-19,Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy,GlobeNewswire
Jan-17-19,"The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US",Benzinga
Feb-19-19,Aptinyx Initiates Phase 2 Study to Evaluate Safety and Efficacy of NYX-783 in Patients with Post-Traumatic Stress Disorder,GlobeNewswire
Feb-22-19,Aptinyx to Present at 8th Annual SVB Leerink Global Healthcare Conference,GlobeNewswire
Mar-06-19,Aptinyx to Present at Cowen and Company 39th Annual Health Care Conference,GlobeNewswire
Mar-14-19,"Aptinyx to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 21, 2019",GlobeNewswire
Mar-21-19,Aptinyx Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress,GlobeNewswire
Mar-22-19,Aptinyx to Present Preclinical Data on NYX-458 at the AD/PD 14th International Conference on Alzheimers & Parkinsons Diseases,GlobeNewswire
Mar-27-19,All You Need to Know About Aptinyx Inc. (APTX) Rating Upgrade to Buy,Zacks
Mar-28-19,Aptinyx to Present Detailed Results from Phase 2 Painful DPN Study of NYX-2925 at American Pain Society Scientific Meeting,GlobeNewswire
Apr-03-19,"Data in Parkinsons Disease Model in Non-human Primates Demonstrate Reversal of Cognitive Deficits with Novel NMDA Receptor Modulator, NYX-458",GlobeNewswire
Apr-04-19,Aptinyx to Present at 18th Annual Needham Healthcare Conference,GlobeNewswire
Apr-18-19,Robust Analgesic Activity of Aptinyxs NYX-2925 in Advanced DPN Patients Revealed Through Further Analysis of Data from Phase 2 Study,GlobeNewswire
Apr-30-19,"Aptinyx Reports Positive Data from Phase 1 Study of Novel NMDA Receptor Modulator, NYX-458, in Healthy Volunteers",GlobeNewswire
May-02-19,Biotech Bets and a Goodbye from a Favorite Expert,MoneyShow
May-06-19,"Aptinyx to Report First Quarter 2019 Financial Results on Tuesday, May 14, 2019",GlobeNewswire
May-07-19,Aptinyx Appoints Henry Gosebruch to Its Board of Directors,GlobeNewswire
May-09-19,Were Hedge Funds Right About Dumping Aptinyx Inc. (APTX) ?,Insider Monkey
May-14-19,Aptinyx Reports First Quarter 2019 Financial Results and Provides Corporate Update,GlobeNewswire
May-28-19,Could The Aptinyx Inc. (NASDAQ:APTX) Ownership Structure Tell Us Something Useful?,Simply Wall St.
